Amanda Connor v. HHS - Tdap, shoulder injury related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
On January 17, 2024, Amanda Connor filed a petition alleging that a tetanus, diphtheria, and acellular pertussis (Tdap) vaccination on or about October 20, 2022 caused a shoulder injury related to vaccine administration. The stipulation also notes that she received a COVID-19 vaccine on January 6, 2023, outside the Vaccine Injury Table.
Respondent denied that Ms. Connor's alleged SIRVA began within the Table timeframe, denied that the Tdap vaccine caused her shoulder injury or any other injury, and denied that her current disabilities were vaccine sequelae.
The public stipulation decision does not describe the first symptom, treatment history, imaging, daily-life effects, expert evidence, or medical mechanism. On September 24, 2025, Chief Special Master Brian H.
Corcoran adopted the parties' stipulation and awarded Ms. Connor a lump sum of $30,000.00 through counsel's IOLTA account.
The stipulation included waiver language for any possible Countermeasures Injury Compensation Program claim involving the later COVID-19 vaccine alone or in combination with the Tdap vaccination.
Theory of causation
Tdap vaccine on or about October 20, 2022, alleged SIRVA; stipulation also notes a later January 6, 2023 COVID-19 vaccine and waiver/withdrawal of related CICP claims if any. COMPENSATED by stipulation. Respondent denied Table-timeframe onset, Tdap causation, and sequelae. Public decision gives no onset/treatment details. Award: $30,000 lump sum for all Section 15(a) damages, ACH to counsel IOLTA. Chief Special Master Corcoran September 24, 2025. Attorney Christopher J. Webb; respondent Mallori Browne Openchowski.
Source PDFs
USCOURTS-cofc-1_24-vv-00060